Conference-FASEB Growth Factor Receptor Tyrosine Kinases

描述（由申请人提供）：我们为FASEB“生长因子受体酪氨酸激酶I有丝分裂、形态发生和肿瘤发生”系列夏季研究会议中的第三次会议寻求部分支持，该会议将于2003年8月2日至8月7日在亚利桑那州图森举行。本次会议将以1999年和2001年两次会议的成功为基础，继续关注生长因子受体酪氨酸激酶重要类别的生物学和病理生理学的新进展，因为它们与有丝分裂、发育、形态发生、肿瘤发生和肿瘤进展有关。由于酪氨酸激酶领域的广泛，与之前的会议一致，我们将继续强调与受体酪氨酸激酶ErbB和Met家族相关的最新进展。然而，关于发育系统的会议已经扩展到包括无脊椎动物受体信号范式，因为这些系统在理解受体信号的综合机制方面处于领先地位。对于这些，和其他独特的受体激酶信号范式，我们将扩大范围超出这些受体。增加了一个新的会议，包括全体会议，讨论受体酪氨酸激酶信号规范的重要和热门问题。科学计划将包括26位受邀演讲者的平台演讲，他们都是各自领域的国际知名领袖。该计划还将包括从摘要中选出的大量口头报告，以及展示所有与会者作品的海报会议。青年研究者小型研讨会，这是前几次会议的一个亮点，将有特色。为了最大限度地促进与会者之间的科学互动，会议出席人数将限制在100-190名研究人员，包括受邀演讲者和从会议申请中选择的个人。我们将努力提供既有资深调查人员也有初级调查人员，并鼓励妇女和少数民族的参与。我们期待这次会议将成功地成为一个关于生长因子受体酪氨酸激酶的最新科学交流的论坛。它将培育新的合作企业，并保持适合FASEB会议系列的高标准。

DESCRIPTION (provided by applicant): We seek partial support for the third in a series of FASEB Summer Research Conferences on "Growth Factor Receptor Tyrosine Kinases I Mitogenesis, Morphogenesis, and Tumorigenesis", to be held in Tucson AZ from August 2 to August 7, 2003. This conference will build upon the success of the two earlier conferences held in 1999 and 2001, and continue to focus on new developments in biology and pathophysiology of important classes of growth factor receptor tyrosine kinases as they relate to mitogenesis, development, morphogenesis, tumorigenesis and tumor progression. Because of the overwhelming breadth of the tyrosine kinase field, consistent with earlier meetings we will maintain some emphasis on recent developments relevant to ErbB and Met families of receptor tyrosine kinases. However, the sessions on developmental systems have been expanded to include invertebrate receptor signaling paradigms, since these systems lead the way on understanding integrative mechanisms of receptor signaling. For these, and other unique receptor kinase signaling paradigms, we will broaden the scope beyond these receptors. A new session, including plenary talk, has been added to discuss the important and topical question of signal specification by receptor tyrosine kinases. The Scientific Program will include platform presentations by 26 invited speakers, internationally renowned leaders in their respective areas. The program will also include a significant number of oral presentations selected from the Abstracts, and also Poster Sessions to showcase work by all attendees. A Young Investigator Mini-Symposium, which was a highlight of the previous conferences, will be featured. In order to maximize scientific interactions among participants, conference attendance will be limited to 100-190 investigators including invited speakers and individuals selected from the conference applications. We will endeavor to provide a mix of established and junior investigators, with participation by women and minorities encourage. We anticipate that this conference will succeed in serving as a forum for state-of-the-art scientific interchange on growth factor receptor tyrosine kinases. It will foster new collaborative enterprises, and maintain the high standards appropriate to the FASEB Conference series.